0001209191-19-049501.txt : 20190913
0001209191-19-049501.hdr.sgml : 20190913
20190913170906
ACCESSION NUMBER: 0001209191-19-049501
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190911
FILED AS OF DATE: 20190913
DATE AS OF CHANGE: 20190913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOY BERTRAND
CENTRAL INDEX KEY: 0001197452
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33957
FILM NUMBER: 191093190
MAIL ADDRESS:
STREET 1: C/O ENTEGRIS, INC.
STREET 2: 129 CONCORD RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC
CENTRAL INDEX KEY: 0001123494
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043306140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL RD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: 5088938999
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-11
0
0001123494
HARVARD BIOSCIENCE INC
HBIO
0001197452
LOY BERTRAND
C/O HARVARD BIOSCIENCE, INC.
84 OCTOBER HILL RD.
HOLLISTON
MA
01746
1
0
0
0
Common Stock
2019-09-11
4
P
0
15590
3.01
A
138674
D
Common Stock
2019-09-12
4
P
0
11297
3.07
A
149971
D
Common Stock
2019-09-13
4
P
0
7372
3.11
A
157343
D
Common Stock
68466
I
by The BZH Trust
This transaction was executed in multiple trades at prices ranging from $2.93 to $3.10, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) a deferred stock award of 6,600 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019; (b) a deferred stock award of 35,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 16, 2019, immediately prior to the commencement of such meeting, and (ii) May 23, 2020; (c) a deferred stock award of 7,000 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019; and (d) 89,974 shares of common stock held by the Reporting Person
This transaction was executed in multiple trades at prices ranging from $2.97 to $3.14, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes the awards referenced in clauses (a) through (c) of footnote (2) above, plus 101,271 shares of common stock held by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $3.04 to $3.14, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes the awards referenced in clauses (a) through (c) of footnote (2) above, plus 108,643 shares of common stock held by the Reporting Person.
This form has been signed under power of attorney.
/s/ Chad Porter, by power of attorney
2019-09-13